MENU
+Compare
SRDX
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$27.57
Change
-$0.57 (-2.03%)
Capitalization
397.04M

SRDX Surmodics Forecast, Technical & Fundamental Analysis

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays... Show more

SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SRDX with price predictions
Apr 17, 2025

SRDX sees MACD Histogram crosses below signal line

SRDX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 08, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SRDX as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SRDX's RSI Indicator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where SRDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRDX advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.250) is normal, around the industry mean (23.907). P/E Ratio (71.513) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.838) is also within normal values, averaging (42.115).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SRDX is expected to report earnings to rise 133.25% to -9 cents per share on April 30

Surmodics SRDX Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.42
The last earnings report on January 30 showed earnings per share of -3 cents, beating the estimate of -11 cents. With 46.49K shares outstanding, the current market capitalization sits at 397.04M.
A.I. Advisor
published General Information

General Information

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9924 West 74th Street
Phone
+1 952 500-7000
Employees
376
Web
https://www.surmodics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

SRDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-2.03%
PXMBF - SRDX
41%
Loosely correlated
N/A
PRCT - SRDX
27%
Poorly correlated
+0.42%
UFPT - SRDX
27%
Poorly correlated
+2.73%
PACB - SRDX
26%
Poorly correlated
-2.50%
TMDX - SRDX
26%
Poorly correlated
+3.35%
More